BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 1999

View Archived Issues

ACE inhibitor quinaprilat stimulates angiogenesis in vivo

Read More

Oral mucositis prevention with IB-367 assessed

Read More

Chinese herbal medicine demonstrates high efficacy against influenza in mice

Read More

Therion Biologics completes financing, accelerates therapeutic vaccine programs

Read More

Phase I trial of ThGRF1-44 successfully completed

Read More

NeoPharm announces CRADA with NCI for novel anticancer compound

Read More

Protein Design Labs enters agreement with Fujisawa

Read More

Emisphere and Elan restructure joint venture for development and marketing of oral heparin

Read More

In the news: Elan's novel approach to treatment and prevention of AD

Read More

Citicoline combination treatment shows synergistic effect in reducing stroke infarct volume

Read More

Phase III combination trial begins for ranolazine in stable angina

Read More

Pediatric formulation of Viramune now available in the E.U.

Read More

Teijin patents novel and clinically useful factor Xa inhibitors

Read More

Midostaurin is a promising new agent for preventing vision loss

Read More

Cytokine production inhibitors in the pipeline at Sankyo

Read More

Metabolite of previously reported compound acts as potent, selective 5-HT4 receptor antagonist

Read More

Ono synthesizes compounds that inhibit adhesion molecule expression

Read More

Novel FGF discovered at Genentech; antibodies useful for treating, diagnosing tumors

Read More

Valentis investigates multiple gene therapy approaches to treatment of arthritis

Read More

Selective beta3-receptor agonists in early development at Lilly

Read More

Potential new spinal analgesic --MPV-2426-- characterized at Orion

Read More

Enspheres are an efficient delivery system for DNA

Read More

New nitrone derivative protects against oxidative stress-induced damage

Read More

Gene therapy AD21 evaluated in phase I study in cancer patients

Read More

LM-1484 should be very effective therapy for bronchial asthma according to preclinical data

Read More

MetXia-P450 for GDEPT of cancer

Read More

Vaxin develops technology for transdermal vaccine delivery

Read More

Abaperidone undergoes extensive efficacy and safety testing at Ferrer

Read More

Eisai in-licenses novel antiarthritic from Knoll

Read More

FDA advisory committee to consider OTC status for Flexeril

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing